Comparing the outcome of patients with adjuvant or salvage treatment in clinical unilateral T3a prostate cancer Hsu C.y.1, Joniau S.1, Oyen R.2, Roskams T.3, Van Poppel H.1 1KULeuven, Urology, Leuven, Belgium, 2KULeuven, Radiology, Leuven, Belgium, 3KULeuven, Pathology, Leuven, ...
- 《Cancer》 被引量: 189发表: 2004年 Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: w... BACKGROUNDThe objective of the current study was to report biochemical recurrence–free survival (b...
RADICAL PROSTATECTOMY FOR VERY HIGH RISK T3B/4 PROSTATE CANCER - LONG TERM RESULTS OF A MULTIINSTITUTIONAL EXPERIENCE May 21, 2012 01:00 PMProstate Cancer: Localized VnoneProstate cancer (PCa) pts. with cT3b/4-tumor are at high risk for disease progression and cancer related death. According...
We evaluated the resectability rate and clinical response rate to 16 weeks of total androgen blockage therapy for clinically locally prostate cancer before radical prostatectomy, and progression-free survival in this multi-institutional study. Southwest Oncology Group 9109 was a phase II feasibility study...
cancer17and prostate cancer16. Interestingly, Guo and colleagues have reported that IMD is overexpressed in HCC and regulates HCC cell proliferation and survival19. They found that blocking IMD signaling inhibited HCC growth in a dose-dependent manner by inducing apoptosis, findings that are ...
cancerpatients’operationriskandalsoreducespositivemarginratesandbloodloss,meanwhile,itnotonlycanimproves5-yearPSA-freesurvivalratesbutalsoimprove5-yeardisease-fleesurvivalratessignificantly,especiallyformediumandlOWriskprostatecancerpatients.KeyWordsradicalprostatectomy;neoadjuvanthormonaltherapy;T3bNOM0periodprostateCanCer6...
Five year follow up of a phase II study of cytotoxic immunotherapy combined with radiation in newly diagnosed prostate cancer In the U.S. there are about 70,000 annual prostate cancer recurrences. The purpose of this study is to evaluate a product to decrease incidence of recurrence. This stud...
SURVIVAL ratePROSTATE cancerPurpose: Pathologic T3b (pT3b) prostate cancer, characterized by seminal vesicle invasion (SVI), exhibits variable oncological outcomes post-radical prostatectomy (RP). Identifying prognostic factors is crucial for patient-specific management. This study invest...
Methods. The records of a total of 738 patients with localized prostate cancer treated with external beam radiotherapy (RT) and no androgen deprivation at our institution between July 1986 and February 1999 were reviewed. Two risk groups were defined: favorable (Stage T1-T2, pretreatment prostate-...
2063 T3 Prostate cancer: Induction androgen suppression combined with prostatectomy does not surpass definitive irradiationdoi:10.1016/S0360-3016(97)85639-8International Journal of Radiation Oncology*Biology*PhysicsLeonard Gomella and Richard Valicenti and Theresa Hyslop and S. Grant Mulholland and Stuart ...